Related Experiment Video

Updated: Aug 8, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 12, 2013

Multiple effects of interferon on the replication of human immunodeficiency virus type 1

P M Pitha1

  • 1Oncology Center, Johns Hopkins University, Baltimore, MD 21231.

Antiviral Research
|July 1, 1994
PubMed

Insights

Interferon (IFN) inhibits Human Immunodeficiency Virus type 1 (HIV-1) replication through specific molecular mechanisms. This review explores these findings in vitro and their relation to the HIV-1 life cycle.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Interferons (IFNs) are crucial cytokines in innate immunity.
  • Human Immunodeficiency Virus type 1 (HIV-1) is a significant global health challenge.
  • Understanding host-pathogen interactions is key to developing antiviral strategies.

Purpose of the Study:

  • To review the effects of IFN on HIV-1 replication in vitro.
  • To elucidate the molecular mechanisms of IFN-mediated HIV-1 inhibition.
  • To connect these mechanisms with the unique aspects of the HIV-1 replication cycle.

Main Methods:

  • In vitro studies using cell culture models.
  • Analysis of molecular pathways involved in IFN signaling.
  • Comparative analysis of HIV-1 replication dynamics.

Main Results:

  • IFN treatment demonstrably inhibits HIV-1 replication in various model systems.
  • Specific molecular pathways activated by IFN interfere with HIV-1 gene expression and assembly.
  • These inhibitory effects are influenced by unique viral replication strategies.

Conclusions:

  • IFN possesses potent antiviral activity against HIV-1 in vitro.
  • Molecular mechanisms underlying IFN's action provide insights into viral control.
  • Findings highlight potential therapeutic avenues by leveraging IFN-based strategies.

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...